Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1842225

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1842225

U.S. Ashwagandha Supplements Market Size, Share & Trends Analysis Report By Form (Capsules, Tablets & Pills, Powder, Liquid), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

U.S. Ashwagandha Supplements Market Summary

The U.S. ashwagandha supplements market size was estimated at USD 219.9 million in 2024 and is projected to reach USD 465.3 million in 2033, growing at a CAGR of 8.8% from 2025 to 2033. This can be attributed to the rising consumer demand for natural remedies for sleep, stress, immunity, and overall wellness.

In the U.S., the ashwagandha market price has steadily increased, fueled by growing demand for premium forms such as gummies, functional beverages, and concentrated extracts. While standard capsules and powders stay relatively affordable, newer and high-potency products tend to carry higher price points.

The U.S. ashwagandha supplements industry is driven by rising consumer concern over anxiety, stress, and insomnia issues. Rising work-life pressures, hybrid work fatigue, and broader awareness of mental health have led many Americans to seek non-pharmaceutical options for relief. Clinical studies showing that ashwagandha may help lower cortisol levels and improve stress resilience have reinforced consumer trust and provided companies with evidence to support stress-relief claims, making the herb one of the most recognized adaptogens in the U.S. wellness space. The Office of Dietary Supplements (NIH) highlights ashwagandha (Withania somnifera), a traditional Ayurvedic herb, as an adaptogen, with research suggesting it may help reduce stress and anxiety while also promoting improved sleep.

Moreover, there is a growing wellness trend among American consumers. They are increasingly preferring natural, plant-based, and Ayurveda-inspired remedies. This has pushed Ashwagandha beyond niche herbal channels and into mainstream retail as it aligns with solutions like boosting cognitive performance, sustaining energy, and supporting restful sleep. Its positioning as an adaptogen fits the U.S. gradual shift toward preventive health and holistic wellness. It draws in older adults wanting resilience and younger demographics seeking natural ways to improve performance and balance.

In the U.S., distribution and product innovation have become key factors behind the growth of the ashwagandha market. The herb is no longer limited to capsules or powders found in health stores. It is available in gummies, protein mixes, functional drinks, and even sleep aids through major retailers and online platforms. The rise of e-commerce and direct-to-consumer brands has made these products far more accessible. At the same time, influencer marketing, online reviews, and social media trends continue to draw in new users. This wider availability across formats has encouraged trial and repeat purchases, further fueling market expansion.

U.S. Ashwagandha Supplements Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. ashwagandha supplements market report based on form and distribution channel.

  • Form Outlook (Revenue, USD Million, 2021 - 2033)
  • Capsules
  • Tablets & Pills
  • Powder
  • Liquid
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
Product Code: GVR-4-68040-746-6

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Form Outlook
  • 2.3. Distribution Channel Outlook
  • 2.4. Competitive Outlook

Chapter 3. U.S. Ashwagandha Supplements Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Industry Value Chain Analysis
    • 3.2.1. Sales/Retail Channel Analysis
    • 3.2.2. Profit Margin Analysis
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
    • 3.3.3. Market Opportunities
    • 3.3.4. Market Challenges
  • 3.4. Industry Analysis - Porter's Five Forces Analysis
  • 3.5. Market Entry Strategies

Chapter 4. U.S. Ashwagandha Supplements Market: Form Estimates & Trend Analysis

  • 4.1. Form Movement Analysis & Market Share, 2024 & 2033
  • 4.2. Capsules
    • 4.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 4.3. Tablets & Pills
    • 4.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 4.4. Powder
    • 4.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 4.5. Liquid
    • 4.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 4.6. Others
    • 4.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 5. U.S. Ashwagandha Supplements Market: Distribution Channel Estimates & Trend Analysis

  • 5.1. Distribution channel Movement Analysis & Market Share, 2024 & 2033
  • 5.2. Hospital Pharmacy
    • 5.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.3. Retail Pharmacy
    • 5.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.4. Online Pharmacy
    • 5.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 6. Competitive Analysis

  • 6.1. Recent developments & impact analysis, by key market participants
  • 6.2. Company Categorization
  • 6.3. Participant's Overview
  • 6.4. Financial Performance
  • 6.5. Product Benchmarking

.6. Company Market Share Analysis, 2024 (%)

  • 6.7. Company Heat Map Analysis
  • 6.8. Strategy Mapping
  • 6.9. Company Profiles
    • 6.9.1. Goli Nutrition
      • 6.9.1.1. Company Overview
      • 6.9.1.2. Financial Performance
      • 6.9.1.3. Product Portfolios
      • 6.9.1.4. Strategic Initiatives
    • 6.9.2. NOW Foods
      • 6.9.2.1. Company Overview
      • 6.9.2.2. Financial Performance
      • 6.9.2.3. Product Portfolios
      • 6.9.2.4. Strategic Initiatives
    • 6.9.3. Nature's Way
      • 6.9.3.1. Company Overview
      • 6.9.3.2. Financial Performance
      • 6.9.3.3. Product Portfolios
      • 6.9.3.4. Strategic Initiatives
    • 6.9.4. Gaia Herbs
      • 6.9.4.1. Company Overview
      • 6.9.4.2. Financial Performance
      • 6.9.4.3. Product Portfolios
      • 6.9.4.4. Strategic Initiatives
    • 6.9.5. Himalaya Wellness
      • 6.9.5.1. Company Overview
      • 6.9.5.2. Financial Performance
      • 6.9.5.3. Product Portfolios
      • 6.9.5.4. Strategic Initiatives
    • 6.9.6. Organic India
      • 6.9.6.1. Company Overview
      • 6.9.6.2. Financial Performance
      • 6.9.6.3. Product Portfolios
      • 6.9.6.4. Strategic Initiatives
    • 6.9.7. KSM-66 (Ixoreal Biomed)
      • 6.9.7.1. Company Overview
      • 6.9.7.2. Financial Performance
      • 6.9.7.3. Product Portfolios
      • 6.9.7.4. Strategic Initiatives
    • 6.9.8. NutraHerbals
      • 6.9.8.1. Company Overview
      • 6.9.8.2. Financial Performance
      • 6.9.8.3. Product Portfolios
      • 6.9.8.4. Strategic Initiatives
    • 6.9.9. Solaray
      • 6.9.9.1. Company Overview
      • 6.9.9.2. Financial Performance
      • 6.9.9.3. Product Portfolios
      • 6.9.9.4. Strategic Initiatives
    • 6.9.10. Pure Encapsulations
      • 6.9.10.1. Company Overview
      • 6.9.10.2. Financial Performance
      • 6.9.10.3. Product Portfolios
      • 6.9.10.4. Strategic Initiatives
Product Code: GVR-4-68040-746-6

List of Tables

  • 1. U.S. ashwagandha supplements market - Key market driver analysis
  • 2. U.S. ashwagandha supplements market - Key market restraint analysis
  • 3. U.S. ashwagandha capsules market estimates and forecast, 2021 - 2033 (USD Million)
  • 4. U.S. ashwagandha tablets & pills market estimates and forecast, 2021 - 2033 (USD Million)
  • 5. U.S. ashwagandha powder supplements market estimates and forecast, 2021 - 2033 (USD Million)
  • 6. U.S. ashwagandha liquid supplements market estimates and forecast, 2021 - 2033 (USD Million)
  • 7. U.S. ashwagandha supplements market estimates and forecast, from other forms, 2021 - 2033 (USD Million)
  • 8. U.S. ashwagandha supplements market estimates and forecast through hospital pharmacy channel, 2021 - 2033 (USD Million)
  • 9. U.S. ashwagandha supplements market estimates and forecast through retail pharmacy channel, 2021 - 2033 (USD Million)
  • 10. U.S. ashwagandha supplements market estimates and forecast through online pharmacy channel, 2021 - 2033 (USD Million)

List of Figures

  • 1. U.S. ashwagandha supplements market snapshot
  • 2. U.S. ashwagandha supplements market segmentation & scope
  • 3. U.S. ashwagandha supplements market value chain analysis
  • 4. U.S. ashwagandha supplements market dynamics
  • 5. U.S. ashwagandha supplements market Porter's Five Forces analysis
  • 6. U.S. ashwagandha capsules market estimates and forecast, 2021 - 2033 (USD Million)
  • 7. U.S. ashwagandha tablets & pills market estimates and forecast, 2021 - 2033 (USD Million)
  • 8. U.S. ashwagandha powder supplements market estimates and forecast, 2021 - 2033 (USD Million)
  • 9. U.S. ashwagandha liquid supplements market estimates and forecast, 2021 - 2033 (USD Million)
  • 10. U.S. ashwagandha supplements market estimates and forecast, from other forms, 2021 - 2033 (USD Million)
  • 11. U.S. ashwagandha supplements market estimates and forecast through hospital pharmacy channel, 2021 - 2033 (USD Million)
  • 12. U.S. ashwagandha supplements market estimates and forecast through retail pharmacy channel, 2021 - 2033 (USD Million)
  • 13. U.S. ashwagandha supplements market estimates and forecast through online pharmacy channel, 2021 - 2033 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!